History of Research on Choriocarcinoma: from the Experience of Peking Union Medical College Hospital to the International Clinical Practice
-
摘要: 绒毛膜癌是一种高度恶性的妇科肿瘤,侵袭性高, 早期可经血行转移至全身而成为全身性疾病。20世纪60年代前,因缺乏有效治疗方法,绒毛膜癌患者死亡率高达90%。1949年以来,在宋鸿钊院士带领下,北京协和医院对绒毛膜癌的发生、发展、诊断与治疗进行了一系列研究,并取得开创性成果。经团队不懈努力,将“死亡率90%以上”反转为“总体治愈率90%以上”,极大推动了该领域学术水平的发展。目前我国在该领域研究中仍处于国际领先地位,北京协和医院经验得到国际同行认可并被写入国际指南。Abstract: Choriocarcinoma is a highly invasive malignant gynecological carcinoma. Widespread metastases can occur by bloodstream in the early stage. Before 1960s, due to the lack of effective treatments, its mortality rate was above 90%. Since 1949, under the leadership of Academician SONG Hong-zhao, Peking Union Medical College Hospital has conducted a series of research on the pathogenesis, development, diagnosis and treatment of choriocarcinoma, and has achieved groundbreaking results. His team members are continuing to make unremitting efforts. Their work plays an important role in enhancing the research level in this field. Now, the overall cure rate of choriocarcinoma is over 90%. At present, China has maintained the cutting edge of this field. Efforts by Peking Union Medical College Hospital has been recognized by their overseas counterparts and written into the international guidelines of Choriocarcinoma.
-
Key words:
- choriocarcinoma /
- chemotherapy /
- reproductive function /
- clinical stage /
- drug resistance mechanism
利益冲突 无 -
[1] Sung HC, Wu PC, Ho TH. Treatment of choriocarcinoma and chorioadenoma destruens with 6-mercaptopurine and surgery. A clinical report of 93 cases[J]. Chin Med J, 1963, 82:24-38. [2] Sung HC, Wu PC, Yang HY. Reevaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms[J]. Am J Obstet Gynecol, 1984, 150:69-75. doi: 10.1016/S0002-9378(84)80112-X [3] Song HZ, Wu PC, Wang YE, et al. Pregnancy outcomes after successful chemotherapy for choriocarcinoma and invasive mole: long-term follow-up[J]. Am J Obstet Gynecol, 1988, 158:538-545. doi: 10.1016/0002-9378(88)90021-X [4] Song HZ, Wu BZ, Tang MY, et al. A staging system of gestational trophoblastic neoplasms based on the development of the disease[J]. Chin Med J (Engl), 1984, 97:557-566. https://www.ncbi.nlm.nih.gov/pubmed/6097412 [5] 杨秀玉, 宋鸿钊.滋养细胞疾病诊断与治疗中的问题及对策[J].中华妇产科杂志, 1996, 31:195-198. doi: 10.3760/j.issn:0529-567X.1996.04.001 [6] 宋鸿钊, 曾梅珍.绒癌和恶性葡萄胎的根治疗法[J].癌症, 1982, 3:197-203. [7] 宋鸿钊.晚期绒癌的处理[J].中国实用妇科与产科杂志, 1993, 9:334-335. [8] 向阳.宋鸿钊滋养细胞肿瘤学[M].第3版.北京: 人民卫生出版社, 2011: 25-35. [9] Sung HC, Wu PC, Hu MH, et al. Roentgenologic manifestations of pulmonary metastases in choriocarcinoma and invasive mole[J]. Am J Obstet Gynecol, 1982, 142:89-97. doi: 10.1016/S0002-9378(16)32289-X [10] Ngan HY, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease[J]. Int J Gynaecol Obstet, 2015, 131 Suppl 2:S123-S126. https://www.ncbi.nlm.nih.gov/pubmed/8381709 [11] 韩冰, 向阳, 冯凤芝, 等.内质网蛋白质折叠分子伴侣在氟尿苷耐药绒毛膜癌JeG-3/FUDRA细胞中的作用[J].中华妇产科杂志, 2013, 48:41-45. doi: 10.3760/cma.j.issn.0529-567x.2013.01.010 [12] 赵静, 向阳.绒癌耐药机制的研究现状[J].中国癌症防治杂志, 2014, 6:105-108. doi: 10.3969/j.issn.1674-5671.2014.02.02 [13] Zhao J, Lv WG, Feng FZ, et al. Placental site trophoblastic tumor: A review of 108 cases and their implications for prognosis and treatment[J]. Gynecol Oncol, 2016, 142:102-108. doi: 10.1016/j.ygyno.2016.05.006 [14] Ngan HYS, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease[J]. Int J Gynaecol Obstet, 2018, 143: 79-85. doi: 10.1002/ijgo.12615
点击查看大图
计量
- 文章访问数: 318
- HTML全文浏览量: 24
- PDF下载量: 219
- 被引次数: 0